Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL
The purpose of this study is to test the hypothesis that Jetstream atherectomy followed by Ranger or IN.PACT Paclitaxel Drug Coated Balloon (DCB) improves target lesion revascularization at 1 year follow-up when compared to
balloon angioplasty followed by Ranger or IN.PACT in the treatment of femoropopliteal arterial denovo disease.
A prospective, multicenter, randomized study evaluating the use of Jetstream Atherectomy (JS) followed by DCB in comparison to the use of balloon angioplasty (PTA) followed by DCB alone in the treatment of complex lesions in femoropopliteal arteries in subjects with claudication (Rutherford Clinical Category (RCC) of 2-4) (complex lesions are defined as long (. 10 cm) lesions, or moderately or highly calcified lesions, or chronic total occlusions irrespective of length)
Status | Finished |
---|---|
Effective start/end date | 7/2/19 → 2/4/20 |
Funding
- Midwest Cardiovascular Research Foundation: $8,702.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.